Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the health-check domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /dom76025/wp-includes/functions.php on line 6121
Itch Archives - Page 8 of 12 - The Dermatology Digest
Search

Nemolizumab Update: Galderma’s IL-31 Blocker Receives Filing Acceptances for PN and AD in Four More Countries

Galderma’s nemolizumab has received filing acceptances for prurigo nodularis (PN) and atopic dermatitis (AD) in Australia, Singapore, Switzerland, and the United Kingdom. These countries or regulatory authorities are members of the Access Consortium. An approval decision is expected from the consortium next year. Nemolizumab inhibits interleukin (IL)-31 signaling to provide relief from itch. These acceptances […]